| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 7 | |
| #2 | Canada | 2 | |
| #3 | China | 2 | |
| #4 | United States | 2 | |
| #5 | WIPO (World Intellectual Property Organization) | 2 | |
| #6 | Australia | 1 | |
| #7 | Hong Kong | 1 | |
| #8 | Japan | 1 | |
| #9 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry | |
| #4 | Measurement | |
| #5 | Agriculture |
| # | Name | Total Patents |
|---|---|---|
| #1 | Luebbert Hermann | 7 |
| #2 | Gordon Douglas | 4 |
| #3 | Ullmer Christoph | 4 |
| #4 | Froimowitz Mark | 4 |
| #5 | Hoffmann Ralf | 3 |
| #6 | Bellott Emile | 3 |
| #7 | Zwilling Stefan | 3 |
| #8 | Goppelt Andreas | 2 |
| #9 | Lubbert Hermann | 2 |
| #10 | Schmitz Beate | 2 |
| Publication | Filing date | Title |
|---|---|---|
| EP1655027A1 | 9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension and migraine | |
| AU2003210347A1 | Cathepsin y for the treatment of pain | |
| CN1575291A | Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist | |
| EP1234816A1 | Scyphostatin analogues as SMase inhibitors | |
| EP1081225A1 | Transgenic animal model for neurodegenerative diseases |